炎症标志物与肾功能不全进展的关联:在1型糖尿病患者中考察不同评估时间窗
基于DCCT/EDIC队列中1型糖尿病患者28年随访数据,在四个时间点检测炎症、内皮功能障碍及纤溶标志物。多变量事件时间分析显示,sTNFR-1/2、sE-selectin、纤维蛋白原和PAI-1与后续肾功能不全进展相关,且在3年和10年时间窗内均存在关联。
要点
- sTNFR-1/2、sE-selectin、纤维蛋白原和PAI-1与1型糖尿病肾功能不全进展相关。
- 上述标志物的关联在3年和10年随访时间窗内均存在。
- 部分标志物的关联在不同随访时间窗之间有所变化。
核心结论
- 血浆炎症、内皮功能障碍和凝血/纤溶标志物与1型糖尿病患者的肾功能不全进展相关,在短期和长期随访中均存在关联。
研究设计与样本
- 在DCCT/EDIC队列的1型糖尿病患者中,于28年治疗和随访期间的四时间点检测生物标志物。
- 采用前瞻性多变量事件时间分析,评估每个标志物与预设时间间隔(3年和10年窗口)内后续事件的关联。
主要发现
- 多变量事件时间模型显示,sTNFR-1/2、sE-selectin、纤维蛋白原和PAI-1与后续肾功能不全发生显著相关。
- 部分标志物在不同随访时间窗之间的关联存在变化,但sTNFR-1/2、sE-selectin、PAI-1和纤维蛋白原在3年和10年窗口内均与慢性肾脏病进展相关。
关键数值与推荐
- 肾脏结局定义为进展为新发慢性肾脏病(3期或更严重)或大量白蛋白尿(白蛋白排泄率≥300 mg/24 h)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether biomarkers of inflammation and endothelial dysfunction are associated with the development of kidney dysfunction and the time frame of their association. RESEARCH DESIGN AND METHODS: Biomarkers were measured at four time points during 28 years of treatment and follow-up in patients with type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort. In addition to traditional biomarkers of inflammation (C-reactive protein and fibrinogen), we measured interleukin-6 (IL-6) and soluble tumor necrosis factor receptors 1 and 2 (sTNFR-1/2), markers of endothelial dysfunction (soluble intracellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin [sE-selectin]), and fibrinolysis (total and active plasminogen activator inhibitor-1 [PAI-1]). Renal outcomes were defined as progression to incident chronic kidney disease (stage 3 or more severe) or macroalbuminuria (albumin excretion rate ≥300 mg/24 h). Prospective multivariate event-time analyses were used to determine the association of each biomarker with each subsequent event within prespecified intervals (3-year and 10-year windows). RESULTS: Multivariate event-time models indicated that several markers of inflammation (sTNFR-1/2), endothelial dysfunction (sE-selectin), and clotting/fibrinolysis (fibrinogen and PAI-1) are significantly associated with subsequent development of kidney dysfunction. Although some markers showed variations in the associations between the follow-up windows examined, the results indicate that biomarkers (sTNFR-1/2, sE-selectin, PAI-1, and fibrinogen) are associated with progression to chronic kidney disease in both the 3-year and the 10-year windows. CONCLUSIONS: Plasma markers of inflammation, endothelial dysfunction, and clotting/fibrinolysis are associated with progression to kidney dysfunction in type 1 diabetes during both short-term and long-term follow-up.
引用
- Baker NL, Hunt KJ, Stevens DR, et al. Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes. Diabetes Care. 2017. PMID: 29118060. doi:10.2337/dc17-0867
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。